SS Innovations International Inc. (NASDAQ: SSII), a developer of surgical robotic technologies, has appointed veteran medical technology finance executive Sarah M. Romano as chief financial officer, effective August 3, 2026. The appointment adds significant public-company financial and capital markets experience as the company accelerates global expansion and regulatory initiatives.
Romano brings more than two decades of experience in public-company finance, capital markets, and medical technology, having raised over $100 million during her career. She joins SS Innovations after serving as CFO at Vicarious Surgical, another robotic surgical technology developer, where she oversaw financial and operational initiatives to reduce cash burn and strengthen the balance sheet.
The appointment comes at a pivotal time for SS Innovations as it pursues broader commercialization of its SSi Mantra surgical robotic platform while continuing preparations for U.S. Food and Drug Administration review (https://nnw.fm/yY4UM). The company is also expanding its international footprint, with its SS International Centre for Robotics Surgery (SSICRS) recently graduating the inaugural class of its cardiac robotic surgery training program. SSICRS welcomed 33 healthcare professionals from seven countries, underscoring the company's emphasis on surgeon education alongside technology deployment.
This strategic leadership addition signals SS Innovations' commitment to strengthening its financial foundation as it navigates the regulatory pathway in the United States and scales its global operations. The company's focus on training surgeons from multiple countries highlights its approach to building a skilled user base that can drive adoption of its technology worldwide.
For investors and industry observers, Romano's appointment suggests a heightened focus on financial discipline and capital efficiency as the company prepares for potential U.S. market entry. The surgical robotics sector continues to be highly competitive, and SS Innovations' ability to secure experienced leadership with a track record of raising capital and managing public-company finances could be critical to its success.
The expansion of the SSICRS training program also has implications for the broader healthcare industry, as it indicates growing interest in robotic-assisted cardiac surgery across international markets. By training surgeons from diverse regions, SS Innovations is laying the groundwork for a global user community that could accelerate clinical adoption and generate real-world evidence to support regulatory submissions.
As SS Innovations moves forward, the combination of Romano's financial expertise and the company's technological advancements positions it to potentially make significant strides in the surgical robotics field. The latest news and updates relating to SSII are available in the company's newsroom at https://nnw.fm/SSII.
